T lymphocytes ... the same cellscausegraft versus host disease ( GVHD
The cells are irradiatedto preventgraft - versus - host disease
the t - cells ... only the onescausegraft versus host disease
the toxic cellstriggergraft - versus - host disease
Those cells are engineeredto preventgraft versus host disease ( GVHD
the activated T - cellscausinggraft - versus host disease ( GVHD
munoregulatory T cellspreventgraft - versus - host - disease
engineered T - cellsto causegraft versus host disease
transfer of allogeneic T cellscan causegraft versus host disease ( GvHD
some light ... the immune cellscausegraft - versus - host disease ( GVHD
the immune cells ... when they startcausinggraft versus host disease
the donor T cells ... to helppreventgraft versus host disease
the elimination of pre - T - cellscausegraft versus host disease ( GvHD
Engineered regulatory T cellspreventgraft - versus - host disease
Figure 7 from Ex vivo - expanded CD4+CD25 + immunoregulatory T cellspreventgraft - versus - host - disease
Figure 3 from Ex vivo - expanded CD4+CD25 + immunoregulatory T cellspreventgraft - versus - host - disease
Figure 6 from Ex vivo - expanded CD4+CD25 + immunoregulatory T cellspreventgraft - versus - host - disease
Figure 4 from Ex vivo - expanded CD4+CD25 + immunoregulatory T cellspreventgraft - versus - host - disease
blood cells ... measuresto preventgraft - versus - host disease
donor T cells reacting against(passive) caused bygraft - versus - host disease ( GVHD
the ability to eliminate the T cellsshould ... causeGraft - versus - host disease
Certain types of T cellscausegraft - versus - host disease
transplanted unmatching cellscausing“ graft vs host ” disease
CAR - T cells ... to avoidtriggeringgraft - versus - host - disease ( GVHD
metabolic pathways ... the T cellscausegraft - versus - host disease ( GVHD
using iNK T cellsto preventgraft versus host disease
T - cells ... a kind of lymphocytecausesGraft Versus Host Disease
Allogeneic stem cellsespecially ... may causegraft versus host disease
A disadvantage of these white blood cells iscan ... provokegraft versus host disease
inactivating white blood cellsto preventgraft - versus - host disease
Strober S. Host NKT cellscan preventgraft - versus - host disease
T regulatory cells ( Tregs ... to helppreventgraft - versus - host disease ( GVHD
Haploidentical stem cells ... to helppreventgraft versus host disease ( GVHD
the white blood cells will attack the patientcausinggraft - versus - host disease ( GVHD
The NK cells have decreased potentialto causegraft - versus - host disease
M. Weyand Mature donor T cellscausegraft - versus - host disease ( GVHD
regulatory T cells ( Tregs ) have been shownto effectively preventgraft - versus - host disease ( GVHD
the infusion of MHC - mismatched allogeneic T cellsmay causegraft - versus - host disease ( GVHD
Early infusion of T regulatory Cellsto preventGraft Versus Host Disease
freshly purified T - regulatory cellsto preventgraft - versus - host disease
significant morbidity and mortality in allogeneic hematopoietic stem cell transplantation ( aHSCTcausessignificant morbidity and mortality in allogeneic hematopoietic stem cell transplantation ( aHSCT
significant morbidity and mortality in patients receiving transplants containing allogeneic hematopoietic cellscausessignificant morbidity and mortality in patients receiving transplants containing allogeneic hematopoietic cells
morbidity and mortality after HSCTcausesmorbidity and mortality after HSCT
multiple organ failure(passive) caused bymultiple organ failure
in substantial morbidity and mortalityresultsin substantial morbidity and mortality
severe morbidity and mortality(passive) caused bysevere morbidity and mortality
significant morbidity and mortality among the transplanted patientscausessignificant morbidity and mortality among the transplanted patients
to transplant - related morbidity and mortalitycontributes substantiallyto transplant - related morbidity and mortality
the reduction of Transplant Related Mortality(passive) caused bythe reduction of Transplant Related Mortality
the really poor quality of life or kill youcan causethe really poor quality of life or kill you
the date of death(passive) caused bythe date of death
to significant morbidity and mortality following allogeneic hematopoietic cell transplantation ( HCTcontributingto significant morbidity and mortality following allogeneic hematopoietic cell transplantation ( HCT
to life - threatening inflammation and organ failurecan leadto life - threatening inflammation and organ failure
skin , liver , or intestinal problemscan causeskin , liver , or intestinal problems
when using these stem cells , similar to umbilical cord stem cells [ 26can be preventedwhen using these stem cells , similar to umbilical cord stem cells [ 26
morbidity and mortality in transplant recipients ( 47 , 48 , 49can causemorbidity and mortality in transplant recipients ( 47 , 48 , 49
to serious complications and in worst case deathmay leadto serious complications and in worst case death
to death in 15 % of children and at least 30 % of adults post transplantleadingto death in 15 % of children and at least 30 % of adults post transplant
to tissue damages and deathleadsto tissue damages and death
serious mortality and morbiditycausingserious mortality and morbidity
failure of donor hematopoiesis and lymphopoiesis in interferon - gamma receptor - deficient hosts Jean Sébastien Delisle Institute for Research in Immunology and Cancer , Montreal , QCcausesfailure of donor hematopoiesis and lymphopoiesis in interferon - gamma receptor - deficient hosts Jean Sébastien Delisle Institute for Research in Immunology and Cancer , Montreal , QC
skin problems such as a rash , blisters , or thickening of the skinmay causeskin problems such as a rash , blisters , or thickening of the skin
from a bone marrow transplant ( which she had as I was in my first months of cancer treatmentresultingfrom a bone marrow transplant ( which she had as I was in my first months of cancer treatment
from transplants from unrelated and human leukocyte antigen ( HLA)-mismatched related donorsresultingfrom transplants from unrelated and human leukocyte antigen ( HLA)-mismatched related donors
when the immune cells in the donor ’s stem cells attack the recipient ’s tissuesresultswhen the immune cells in the donor ’s stem cells attack the recipient ’s tissues
all sort of problemsis causingall sort of problems
problems with the eyesmay causeproblems with the eyes
broad suppression of hematopoietic primitive cells and blocks megakaryocyte differentiation in a murine modelcausesbroad suppression of hematopoietic primitive cells and blocks megakaryocyte differentiation in a murine model
broad suppression of hematopoietic primitive cells and block in megakaryocyte differentiation in a murine modelcausesbroad suppression of hematopoietic primitive cells and block in megakaryocyte differentiation in a murine model
a variety of symptoms including nausea , vomiting , diarrhea and a skin rashcan causea variety of symptoms including nausea , vomiting , diarrhea and a skin rash
the tempo of immunologic recovery after allogeneic human marrow transplantationinfluencethe tempo of immunologic recovery after allogeneic human marrow transplantation
in the rejection of tissue transplants in mismatched donorsresultedin the rejection of tissue transplants in mismatched donors
major adverse effects and ... in many cases ... deathcan causemajor adverse effects and ... in many cases ... death
from minor complications to serious events like deathresultingfrom minor complications to serious events like death
rejection of the donated bone marrow and leaves the patient vulnerable to infectioncausesrejection of the donated bone marrow and leaves the patient vulnerable to infection
an immunosuppressive state in which immune protection against infection is inadequatecreatesan immunosuppressive state in which immune protection against infection is inadequate
in the rejection of tissue transplants in HLA - mismatched donorsresultedin the rejection of tissue transplants in HLA - mismatched donors
to longer survival for stem cell transplant recipients and remove the need for potentially harmful prophylactic immune - suppressionmay leadto longer survival for stem cell transplant recipients and remove the need for potentially harmful prophylactic immune - suppression
to the adverse prognoses of treated patientscould leadto the adverse prognoses of treated patients
most non - relapse mortality ( NRMcausesmost non - relapse mortality ( NRM